Personal Home Page

http://138.26.61.118/depts/MEB/SOMResearchFaculty/currentfacultydata.asp?ID=wgrizzle

Articles in Scholarly Journals [Incomplete List]

1. Exploration of associations between phospholipase A2 gene family polymorphisms and AIDS progression using the SNPlex™ method
   Biomedicine & Pharmacotherapy, vol. 62, no. 1, pp. 31–40, 2008
2. Mandatory fortification with folic acid in the United States is associated with increased expression of DNA methyltransferase-1 in the cervix
   Nutrition, vol. 24, no. 1, pp. 94–99, 2008
3. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model
   Gynecologic Oncology, vol. 108, no. 3, pp. 591–597, 2008
4. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
   Nature, vol. 452, no. 7187, Article ID nature06885, 4 pages, 2008
5. SNP and haplotype mapping for genetic analysis in the rat
   Nature Genetics, vol. 40, no. 5, Article ID ng.124, 6 pages, 2008
6. Antibody responses of variable lymphocyte receptors in the lamprey
   Nature Immunology, vol. 9, no. 3, Article ID ni1562, 8 pages, 2008
7. Human PDE4A8, a novel brain-expressed PDE4 cAMP-specific phosphodiesterase that has undergone rapid evolutionary change
   Biochemical Journal, vol. 411, no. 2, p. 361, 2008
8. Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma
   Frontiers in Bioscience, vol. 13, no. 13, p. 1050, 2008
9. Genetic and Haplotypic Structure in 14 European and African Cattle Breeds
   Genetics, vol. 177, no. 2, pp. 1059–1070, 2007
10. Association between Angiotensin-Converting Enzyme Gene Polymorphisms and Diabetic Nephropathy: Case-Control, Haplotype, and Family-Based Study in Three European Populations
    Journal of the American Society of Nephrology, vol. 18, no. 4, pp. 1284–1291, 2007
11. Rapid Identification of Promoter Hypermethylation in Hepatocellular Carcinoma by Pyrosequencing of Etiologically Homogeneous Sample Pools
    Journal of Molecular Diagnostics, vol. 9, no. 4, pp. 510–520, 2007
12. Combination Treatment with TRA-8 Anti Death Receptor 5 Antibody and CPT-11 Induces Tumor Regression in an Orthotopic Model of Pancreatic Cancer
    Clinical Cancer Research, vol. 13, no. 18, pp. 5535s–5543s, 2007
13. TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth
    Molecular Cancer Therapeutics, vol. 6, no. 12, pp. 3198–3207, 2007
14. A high-resolution linkage map for the Z chromosome in chicken reveals hot spots for recombination
    Cytogenetic and Genome Research, vol. 117, no. 1-4, pp. 22–29, 2007
15. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
    Blood, vol. 109, no. 10, pp. 4336–4342, 2007
16. Expression of LIM kinase 1 is associated with reversible G1/S phase arrest, chromosomal instability and prostate cancer
    Molecular Cancer, vol. 6, no. 1, p. 40, 2007
17. p53 Nuclear Accumulation and Bcl-2 Expression in Contiguous Adenomatous Components of Colorectal Adenocarcinomas Predict Aggressive Tumor Behavior
    Journal of Histochemistry and Cytochemistry, vol. 56, no. 3, pp. 305–312, 2007
18. Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4
    PLoS Genetics, vol. 3, no. 4, p. e58, 2007
19. Analytical Validation of Serum Proteomic Profiling for Diagnosis of Prostate Cancer: Sources of Sample Bias
    Clinical Chemistry, vol. 54, no. 1, pp. 44–52, 2007
20. SELDI-TOF MS Whole Serum Proteomic Profiling with IMAC Surface Does Not Reliably Detect Prostate Cancer
    Clinical Chemistry, vol. 54, no. 1, pp. 53–60, 2007
21. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma
    Nature, vol. 448, no. 7152, Article ID nature06014, 3 pages, 2007
22. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
    Nature Genetics, vol. 39, no. 10, Article ID ng2108, 2 pages, 2007
23. A genome-wide association study of global gene expression
    Nature Genetics, vol. 39, no. 10, Article ID ng2109, 5 pages, 2007
24. DNA methylation analysis by pyrosequencing
    Nature Protocols, vol. 2, no. 9, Article ID nprot.2007.314, 10 pages, 2007
25. Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice model
    Gynecologic Oncology, vol. 105, no. 2, pp. 291–298, 2007
26. DNA sequencing by MALDI-TOF MS using alkali cleavage of RNA/DNA chimeras
    Nucleic Acids Research, vol. 35, no. 8, pp. e62–e62, 2007
27. Assessment of Biomarker Expression in Predicting Pathologic Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer
    The Breast Journal, vol. 13, no. 5, pp. 534–535, 2007
28. Inactivation of Smad4 Accelerates KrasG12D-Mediated Pancreatic Neoplasia
    Cancer Research, vol. 67, no. 17, pp. 8121–8130, 2007
29. SIRT1 Is Significantly Elevated in Mouse and Human Prostate Cancer
    Cancer Research, vol. 67, no. 14, pp. 6612–6618, 2007
30. Triptolide Induces Pancreatic Cancer Cell Death via Inhibition of Heat Shock Protein 70
    Cancer Research, vol. 67, no. 19, pp. 9407–9416, 2007
31. Correction: SIRT1 and Prostate Cancer
    Cancer Research, vol. 67, no. 17, pp. 8423–8423, 2007
32. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1773, no. 7, pp. 1116–1123, 2007
33. Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice
    Mechanisms of Ageing and Development, vol. 128, no. 11-12, pp. 672–680, 2007
34. Methionine inhibits cellular growth dependent on the p53 status of cells
    The American Journal of Surgery, vol. 193, no. 2, pp. 274–283, 2007
35. Discrimination between benign and malignant prostate tissue using chromatin texture analysis in 3-D by confocal laser scanning microscopy
    The Prostate, vol. 67, no. 3, pp. 248–254, 2007
36. Multiplex target protein imaging in tissue sections by mass spectrometry – TAMSIM
    Rapid Communications in Mass Spectrometry, vol. 21, no. 6, pp. 823–829, 2007
37. DNA analysis by mass spectrometry—past, present and future
    Journal of Mass Spectrometry, vol. 41, no. 8, pp. 981–995, 2006
38. Celecoxib Inhibits Cellular Growth, Decreases Ki-67 Expression and Modifies Apoptosis in Ovarian Cancer Cell Lines
    Archives of Medical Research, vol. 37, no. 6, pp. 689–695, 2006
39. Utilization of the three high-throughput SNP genotyping methods, the GOOD assay, Amplifluor and TaqMan, in diploid and polyploid plants
    Theoretical and Applied Genetics, vol. 112, no. 6, pp. 1115–1124, 2006
40. Increased Expression of Thymidylate Synthetase (TS), Ubiquitin Specific Protease 10 (USP10) and Survivin is Associated with Poor Survival in Glioblastoma Multiforme (GBM)
    Journal of Neuro-Oncology, vol. 80, no. 3, pp. 261–274, 2006
41. Ovarian expression of markers associated with proliferation or apoptosis in women with diminished ovarian reserve
    Fertility and Sterility, vol. 86, no. 1, pp. 176–185, 2006
42. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model☆
    Gynecologic Oncology, vol. 101, no. 1, pp. 46–54, 2006
43. Ovarian Biopsy in Infertile Patients With Ovarian Dysfunction
    International Journal of Gynecological Pathology, vol. 25, no. 1, pp. 90–94, 2006
44. SNP genotyping using alkali cleavage of RNA/DNA chimeras and MALDI time-of-flight mass spectrometry
    Nucleic Acids Research, vol. 34, no. 3, pp. e18–e18, 2006
45. Cell density influences the effect of celecoxib in two carcinoma cell lines
    Biotechnic & Histochemistry, vol. 81, no. 1, pp. 51–54, 2006
46. Non-random, individual-specific methylation profiles are present at the sixth CTCF binding site in the human H19/IGF2 imprinting control region
    Nucleic Acids Research, vol. 34, no. 19, pp. 5438–5448, 2006
47. Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1
    The EMBO Journal, vol. 26, no. 2, Article ID 7601499, 11 pages, 2006
48. Single-nucleotide polymorphisms: analysis by mass spectrometry
    Nature Protocols, vol. 1, no. 4, Article ID nprot.2006.257, 10 pages, 2006
49. Biomarkers in Diagnosis of Pancreatic Carcinoma in Fine-Needle Aspirates: ATranslational Research Application
    American Journal of Clinical Pathology, vol. 126, no. 4, pp. 572–579, 2006
50. Expressional and Epigenetic Alterations of Placental Serine Protease Inhibitors: SERPINA3 Is a Potential Marker of Preeclampsia
    Hypertension, vol. 49, no. 1, pp. 76–83, 2006
51. Analysis of 14 Candidate Genes for Diabetic Nephropathy on Chromosome 3q in European Populations: Strongest Evidence for Association With a Variant in the Promoter Region of the Adiponectin Gene
    Diabetes, vol. 55, no. 11, pp. 3166–3174, 2006
52. JAB1 Determines the Response of Rheumatoid Arthritis Synovial Fibroblasts to Tumor Necrosis Factor- 
    American Journal Of Pathology, vol. 169, no. 3, pp. 889–902, 2006
53. Multiple Gene Expression Analyses in Paraffin-Embedded Tissues by TaqMan Low-Density Array: Application to Hedgehog and Wnt Pathway Analysis in Ovarian Endometrioid Adenocarcinoma
    Journal of Molecular Diagnostics, vol. 8, no. 1, pp. 76–83, 2006
54. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors
    Oncogene, vol. 24, no. 36, Article ID 1208730, 16 pages, 2005
55. Selective induction of tumor-associated antigens in murine pulmonary vasculature using double-targeted adenoviral vectors
    Gene Therapy, vol. 12, no. 13, Article ID 3302491, 6 pages, 2005
56. Smad4 Inhibits Tumor Growth by Inducing Apoptosis in Estrogen Receptor- -positive Breast Cancer Cells
    Journal of Biological Chemistry, vol. 280, no. 29, pp. 27022–27028, 2005
57. Phase I Study of 90Y-CC49 Monoclonal Antibody Therapy in Patients with Advanced Non-Small Cell Lung Cancer: Effect of Chelating Agents and Paclitaxel Co-Administration
    Cancer Biotherapy Radiopharmaceuticals, vol. 20, no. 5, pp. 467–478, 2005
58. Inaugural Issue for ISBER and CPT
    Cell Preservation Technology, vol. 3, no. 1, pp. 3–4, 2005
59. Best Practices for Repositories I: Collection, Storage, and Retrieval of Human Biological Materials for Research
    Cell Preservation Technology, vol. 3, no. 1, pp. 5–48, 2005
60. Selective Cyclooxygenase-2 Inhibition Produces Heterogeneous Erythema Response to Ultraviolet Irradiation
    Journal of Investigative Dermatology, vol. 125, no. 6, pp. 1317–1320, 2005
61. Genetic Segregation of Spontaneous Erosive Arthritis and Generalized Autoimmune Disease in the BXD2 Recombinant Inbred Strain of Mice
    Scandinavian Journal of Immunology, vol. 61, no. 2, pp. 128–138, 2005
62. Feasibility of performing chemoprevention trials in women at elevated risk of ovarian carcinoma: Initial examination of celecoxib as a chemopreventive agent
    Gynecologic Oncology, vol. 98, no. 3, pp. 376–382, 2005
63. Cholangiocyte Endothelin 1 and Transforming Growth Factor β1 Production in Rat Experimental Hepatopulmonary Syndrome
    Gastroenterology, vol. 129, no. 2, pp. 682–695, 2005
64. Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications
    Clinical Biochemistry, vol. 38, no. 4, pp. 335–350, 2005
65. Pattern of nonspecific (or global) DNA methylation in oral carcinogenesis
    Head & Neck, vol. 27, no. 12, pp. 1061–1067, 2005
66. High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas
    Cancer, vol. 103, no. 10, pp. 2163–2170, 2005
67. DNA analysis by MALDI-TOF mass spectrometry
    Human Mutation, vol. 23, no. 5, pp. 437–441, 2004
68. High-Density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: Implications for haplotype tagging
    Human Mutation, vol. 24, no. 6, pp. 517–525, 2004
69. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat
    Hepatology, vol. 39, no. 6, pp. 1593–1602, 2004
70. Expression of sperm protein 17 (Sp17) in ovarian cancer
    International Journal of Cancer, vol. 108, no. 6, pp. 805–811, 2004
71. Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma
    Cancer, vol. 101, no. 1, pp. 66–76, 2004
72. De novo quantitative bisulfite sequencing using the pyrosequencing technology
    Analytical Biochemistry, vol. 333, no. 1, pp. 119–127, 2004
73. Adenoviral vector–mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells1
    International Journal of Radiation OncologyBiologyPhysics, vol. 58, no. 3, pp. 950–958, 2004
74. The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology
    Urologic Oncology: Seminars and Original Investigations, vol. 22, no. 4, pp. 337–343, 2004
75. Adenovirus-mediated -targeted proapoptotic gene therapy of human prostate cancer
    Molecular Therapy, vol. 10, no. 6, pp. 1059–1070, 2004
76. Nested core collections maximizing genetic diversity in Arabidopsis thaliana
    The Plant Journal, vol. 38, no. 1, pp. 193–202, 2004
77. Prognostic Significance of p27kip-1 Expression in Colorectal Adenocarcinomas Is Associated with Tumor Stage
    Clinical Cancer Research, vol. 10, no. 5, pp. 1743–1752, 2004
78. Nuclear Localization of KLF4 Is Associated with an Aggressive Phenotype in Early-Stage Breast Cancer
    Clinical Cancer Research, vol. 10, no. 8, pp. 2709–2719, 2004
79. Breast Cancer Chemoprevention Phase I Evaluation of Biomarker Modulation by Arzoxifene, a Third Generation Selective Estrogen Receptor Modulator
    Clinical Cancer Research, vol. 10, no. 16, pp. 5403–5417, 2004
80. Promoter Hypermethylation Profile of Kidney Cancer
    Clinical Cancer Research, vol. 10, no. 12, pp. 3972–3979, 2004
81. Expression and Functional Role of CCR9 in Prostate Cancer Cell Migration and Invasion
    Clinical Cancer Research, vol. 10, no. 24, pp. 8743–8750, 2004
82. Intratumor heterogeneity of biomarker expression in breast carcinomas
    Biotechnic & Histochemistry, vol. 79, no. 1, pp. 25–36, 2004
83. Establishing a tumour bank: banking, informatics and ethics
    British Journal of Cancer, vol. 90, no. 6, Article ID 6601678, 4 pages, 2004
84. Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor
    Cancer Gene Therapy, vol. 12, no. 1, Article ID 7700754, 8 pages, 2004
85. CXCL12–CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion
    Laboratory Investigation, vol. 84, no. 12, Article ID 3700181, 10 pages, 2004
86. Duplicating SNPs
    Nature Genetics, vol. 36, no. 8, Article ID ng0804-789, 1 pages, 2004
87. Future potential of the Human Epigenome Project
    Expert Review of Molecular Diagnostics, vol. 4, no. 5, pp. 609–618, 2004
88. Adeno-Associated Virus 2-Mediated Antiangiogenic Cancer Gene Therapy: Long-Term Efficacy of a Vector Encoding Angiostatin and Endostatin over Vectors Encoding a Single Factor
    Cancer Research, vol. 64, no. 5, pp. 1781–1787, 2004
89. DNA Methylation Profiling of the Human Major Histocompatibility Complex: A Pilot Study for the Human Epigenome Project
    PLoS Biology, vol. 2, no. 12, p. e405, 2004
90. Clarification in the Point/Counterpoint Discussion Related to Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometric Identification of Patients with Adenocarcinomas of the Prostate * Proteomic Pattern Complexity Reveals a Rich and Uncharted Continent of Biomarkers
    Clinical Chemistry, vol. 50, no. 8, pp. 1475–1477, 2004
91. Evaluation of Serum Protein Profiling by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Detection of Prostate Cancer: I. Assessment of Platform Reproducibility
    Clinical Chemistry, vol. 51, no. 1, pp. 102–112, 2004
92. Nuclear Accumulation of p53 Is a Potential Marker for the Development of Squamous Cell Lung Cancer in Smokers
    Chest, vol. 123, no. 1, pp. 181–186, 2003
93. Cancer Causes and Control, vol. 14, no. 1, pp. 37–42, 2003
94. The response of extracellular signal-regulated kinase (ERK) to androgen-induced proliferation in the androgen-sensitive prostate cancer cell line, LNCaP
    Biotechnic & Histochemistry, vol. 78, no. 1, pp. 11–16, 2003
95. The use of dimethylsulfoxide as a vehicle in cell culture experiments using ovarian carcinoma cell lines
    Biotechnic & Histochemistry, vol. 78, no. 1, pp. 17–21, 2003
96. Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma
    Human Pathology, vol. 34, no. 10, pp. 1016–1021, 2003
97. Smad4 as a Transcription Corepressor for Estrogen Receptor alpha
    Journal of Biological Chemistry, vol. 278, no. 17, pp. 15192–15200, 2003
98. LIM Kinase 1 Is Essential for the Invasive Growth of Prostate Epithelial Cells: IMPLICATIONS IN PROSTATE CANCER
    Journal of Biological Chemistry, vol. 278, no. 38, pp. 36868–36875, 2003
99. Erratum
    Scandinavian Journal of Immunology, vol. 58, no. 1, pp. 118–118, 2003
100. Expression of Extracellular Matrix Metalloprotease Inducer in Laryngeal Squamous Cell Carcinoma
     The Laryngoscope, vol. 113, no. 8, pp. 1406–1410, 2003
101. Cancer Incidence Among Tiazine Herbicide Manufacturing Workers
     Journal of Occupational and Environmental Medicine, vol. 45, no. 4, pp. 343–344, 2003
102. Inhibition of tumorigenicity by the 5′-untranslated RNA of the human c-myc P0 transcript
     Experimental Cell Research, vol. 288, no. 1, pp. 131–142, 2003
103. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome
     Journal of Hepatology, vol. 38, no. 5, pp. 556–563, 2003
104. Aging, immunity, and tumor susceptibility
     Immunology and Allergy Clinics of North America, vol. 23, no. 1, pp. 83–102, 2003
105. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome
     Gastroenterology, vol. 125, no. 5, pp. 1441–1451, 2003
106. Extension of the GOOD assay for genotyping single nucleotide polymorphisms by matrix-assisted laser desorption/ionization mass spectrometry
     Rapid Communications in Mass Spectrometry, vol. 17, no. 12, pp. 1265–1272, 2003
107. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration
     Cancer, vol. 99, no. 6, pp. 365–371, 2003
108. The pattern of expression of Mn and Cu-Zn superoxide dismutase varies among squamous cell cancers of the lung, larynx, and oral cavity
     Head & Neck, vol. 24, no. 9, pp. 859–867, 2002
109. Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women
     International Journal of Cancer, vol. 98, no. 1, pp. 118–127, 2002
110. BXD recombinant inbred mice represent a novel T cell-mediated immune response tumor model
     International Journal of Cancer, vol. 101, no. 3, pp. 270–279, 2002
111. Genotyping single nucleotide polymorphisms by mass spectrometry
     Mass Spectrometry Reviews, vol. 21, no. 6, pp. 388–418, 2002
112. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27kip-1
     International Journal of Cancer, vol. 97, no. 4, pp. 403–409, 2002
113. Quantitation of Cytosine Deaminase mRNA by Real-Time Reverse Transcription Polymerase Chain Reaction: A Sensitive Method for Assessing 5-Fluorocytosine Toxicity in Vitro
     Analytical Biochemistry, vol. 301, no. 2, pp. 189–199, 2002
114. A Pilot Study of Ovarian Cancer Chemoprevention Using Medroxyprogesterone Acetate in an Avian Model of Spontaneous Ovarian Carcinogenesis
     Gynecologic Oncology, vol. 87, no. 1, pp. 57–63, 2002
115. Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation
     International Journal of Radiation Oncology*Biology*Physics, vol. 54, no. 4, pp. 1180–1193, 2002
116. Transforming growth factor-α: a surrogate endpoint biomarker?1 , *1
     Journal of the American College of Surgeons, vol. 195, no. 2, pp. 149–158, 2002
117. Large-scale genotyping by mass spectrometry: experience, advances and obstacles
     Current Opinion in Chemical Biology, vol. 6, no. 1, pp. 31–38, 2002
118. Genotyping single-nucleotide polymorphisms by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry
     Journal of Chromatography B, vol. 782, no. 1-2, pp. 73–87, 2002
119. Cancer Incidence Among Triazine Herbicide Manufacturing Workers
     Journal of Occupational and Environmental Medicine, vol. 44, no. 11, pp. 1048–1058, 2002
120. Review of the 2002 Annual Meeting of the Biological Stain Commission
     Biotechnic and Histochemistry, vol. 77, no. 4, pp. 181–182, 2002
121. Gamma Camera Dual Imaging with a Somatostatin Receptor and Thymidine Kinase after Gene Transfer with a Bicistronic Adenovirus in Mice
     Radiology, vol. 223, no. 2, pp. 417–425, 2002
122. Down-regulation of Cdc6, a Cell Cycle Regulatory Gene, in Prostate Cancer
     Journal of Biological Chemistry, vol. 277, no. 28, pp. 25431–25438, 2002
123. Effects of Body Weight Gain Reduction Resulting From Chemopreventive Agent Treatment on Mammary Gland Morphology
     Nutrition and Cancer, vol. 43, no. 1, pp. 67–75, 2002
124. Altered global methylation of DNA: An epigenetic difference in susceptibility for lung cancer is associated with its progression
     Human Pathology, vol. 32, no. 8, pp. 856–862, 2001
125. Protease-Activated Receptor 2, a Receptor Involved in Melanosome Transfer, is Upregulated in Human Skin by Ultraviolet Irradiation
     Journal of Investigative Dermatology, vol. 117, no. 6, pp. 1412–1420, 2001
126. Genetic Dissection of Age-Related Changes of Immune Function in Mice
     Scandinavian Journal of Immunology, vol. 54, no. 1-2, pp. 10–20, 2001
127. Nature Biotechnology, vol. 19, no. 9, pp. 838–842, 2001
128. Effects of time and temperature during attachment of sections to microscope slides on immunohistochemical detection of antigens
     Biotechnic and Histochemistry, vol. 76, no. 2, pp. 55–58, 2001
129. Avoiding biohazards in medical, veterinary and research laboratories
     Biotechnic and Histochemistry, vol. 76, no. 4, pp. 183–206, 2001
130. Annals of Surgery, vol. 233, no. 5, pp. 630–638, 2001
131. THE EFFECT OF ISOLATED SOY PROTEIN ON PLASMA BIOMARKERS IN ELDERLY MEN WITH ELEVATED SERUM PROSTATE SPECIFIC ANTIGEN
     The Journal of Urology, vol. 165, no. 1, pp. 294–300, 2001
132. Molecular Differences in Mucoepidermoid Carcinoma and Adenoid Cystic Carcinoma of the Major Salivary Glands
     The Laryngoscope, vol. 111, no. 8, pp. 1373–1378, 2001
133. FATTY ACID SYNTHASE: AN EARLY MOLECULAR MARKER OF PROGRESSION OF PROSTATIC ADENOCARCINOMA TO ANDROGEN INDEPENDENCE
     The Journal of Urology, vol. 165, no. 3, pp. 1027–1032, 2001
134. Bayesian monitoring of a phase 2 chemoprevention trial in high-risk cohorts for prostate cancer
     Urology, vol. 57, no. 4, pp. 220–223, 2001
135. Characterization of the Cyclooxygenase-2 Promoter in an Adenoviral Vector and Its Application for the Mitigation of Toxicity in Suicide Gene Therapy of Gastrointestinal Cancers
     Molecular Therapy, vol. 3, no. 3, pp. 385–394, 2001
136. Immunohistochemical Expression of Molecular Markers in an Avian Model: A Potential Model for Preclinical Evaluation of Agents for Ovarian Cancer Chemoprevention
     Gynecologic Oncology, vol. 81, no. 3, pp. 373–379, 2001
137. Automation in genotyping of single nucleotide polymorphisms
     Human Mutation, vol. 17, no. 6, pp. 475–492, 2001
138. A Targetable, Injectable Adenoviral Vector for Selective Gene Delivery to Pulmonary Endothelium in Vivo
     Molecular Therapy, vol. 2, no. 6, pp. 562–578, 2000
139. The accumulation of ascorbic acid by squamous cell carcinomas of the lung and larynx is associated with global methylation of DNA
     Cancer, vol. 89, no. 1, pp. 171–176, 2000
140. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas
     International Journal of Cancer, vol. 89, no. 5, pp. 423–430, 2000
141. Applied Immunohistochemistry, vol. 8, no. 3, pp. 236–243, 2000
142. Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models
     Gene Therapy, vol. 7, no. 12, pp. 1019–1026, 2000
143. The expression of Ep-CAM (17-1 A)in squamous cell cancers of the lung
     Human Pathology, vol. 31, no. 4, pp. 482–487, 2000
144. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung
     Human Pathology, vol. 31, no. 9, pp. 1068–1073, 2000
145. The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma
     Oncogene, vol. 19, no. 11, pp. 1419–1427, 2000